| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.2M | +20.0% |
| Cost of Revenue | $4.4M | +8.5% |
| Gross Profit | $1.8M | +61.8% |
| R&D Expense | $8.0M | +2.2% |
| SG&A Expense | $11.1M | +32.9% |
| Operating Income | -$21.1M | -13.0% |
| Pre-tax Income | -$19.9M | -7.5% |
| Income Tax | $65K | +132.1% |
| Net Income | -$19.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.6M | +108.1% |
| Short-term Investments | $29.4M | — |
| Accounts Receivable | $1.8M | +74.5% |
| Inventory | $2.1M | +29.9% |
| Current Assets | $44.2M | +107.1% |
| Total Assets | $47.6M | +93.3% |
| Current Liabilities | $6.0M | +18.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.4M | -5.4% |
| Capital Expenditures | $381K | -19.5% |
| Investing Cash Flow | -$16.1M | -290.6% |
| Financing Cash Flow | $37.5M | — |
| Free Cash Flow | -$16.8M | -4.6% |
| -7.7% |
| EPS (Basic) | -$0.82 | +65.1% |
| EPS (Diluted) | -$0.82 | +65.1% |
| Total Liabilities |
| $8.1M |
| +12.1% |
| Stockholders' Equity | $39.5M | +127.1% |